Opening book details…
About this Medicine article
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies by Rizzieri, D. A.; Feldman, E.; DiPersio, J. F.; Gabrail, N.; Stock, W.; Strair, R.; Rivera, V. M.; Albitar, M.; Bedrosian, C. L.; Giles, F. J. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Rizzieri, D. A.; Feldman, E.; DiPersio, J. F.; Gabrail, N.; Stock, W.; Strair, R.; Rivera, V. M.; Albitar, M.; Bedrosian, C. L.; Giles, F. J.
- Publisher
- American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
- Published
- 2008
- Field
- Medicine (Health Sciences)